EICHORCondition: Severe Alopecia Areata · Sponsor: Pfizer
The purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe alopecia areata. Alopecia areata is a condition that causes hair loss. This study is seeking participants who have: * at least 50% scalp hair loss due to alopecia areata. * received varicella vaccination (2 doses) or have been infected by varicella zoster virus before based on blood test reports. * history of clinical response failure to alopecia areata treatment (for children in EU/UK only). All participants in this study will receive either study medicine (ritlecitinib) or placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. One-third of participants will receive ritlecitinib higher dose, one-third participants will receive ritlecitinib lower dose, and one-third participants will receive placebo. The study medicine is a capsule that is taken by mouth. It is taken once each day at home. The study will compare the experiences of participants receiving ritlecitinib to participants receiving placebo. This will help see if ritlecitinib is safe and effective. Participants will take part in this study for 6 months. During this time, they will have 8 study visits at the study clinic. The study team will also call participants about 8 times over the phone.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UCI Dermatology Clinical Research | Irvine, California, United States | — |
| Southern California Clinical Research | Santa Ana, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | — |
| Pediatric Skin Research | Miami, Florida, United States | — |
| Endeavor Health Clinical Operations | Evanston, Illinois, United States | — |
| Endeavor Health Clinical Operations | Skokie, Illinois, United States | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis, Indiana, United States | — |
| Kindred Hair and Skin Center | Marriottsville, Maryland, United States | — |
| Michigan Dermatology Institute | Waterford, Michigan, United States | — |
| Ear, Nose and Throat Consultants, LLC | Omaha, Nebraska, United States | — |
| Skin Specialists, PC dba Schlessinger MD | Omaha, Nebraska, United States | — |
+ 68 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07029711